Axe Compute Inc. is focused on artificial intelligence (AI) compute accessible to all through its access to the Aethir network. By delivering Aethir-provided decentralized global infrastructure, the Company will endeavor to deliver instant access to bare-metal GPUs at scale to innovators and established businesses alike. Dedicated GPU clusters delivered in 48 hours across 200+ locations. It offers Zero Virtualization Overhead, Purpose-Built for AI Workloads, Flat Rate, Zero Egress Fees, and Enterprise-Grade Support and SLAs. It provides 100% bare-metal access.

Employees

Sector

Biotechnology & Medical Research

More about the company

Market Cap	73.66M 64.4M 59.18M 55.16M 105M 7.01B 106M 710M 276M 3.45B 277M 271M 11.88B	P/E 2024	-0.35x	P/E 2025	-0.53x
Enterprise Value	64.54M 56.42M 51.85M 48.33M 91.67M 6.15B 93.06M 622M 242M 3.02B 242M 237M 10.41B	EV / Sales 2024	4.23x	EV / Sales 2025	121x
Free-Float	87.13%	Yield 2024 *	-	Yield 2025	-

06-29	Axe Compute Inc.(NasdaqCM:AGPU) added to Russell Microcap Value Benchmark Index	CI
06-29	Axe Compute Inc.(NasdaqCM:AGPU) added to Russell 3000E Index	CI
06-28	Axe Compute Inc.(NasdaqCM:AGPU) added to Russell 3000E Value Benchmark	CI
06-28	Axe Compute Inc.(NasdaqCM:AGPU) added to Russell Microcap Index	CI
06-16	Axe Compute Inc. Secures $25.9 Million in Contracts for Long-Term Deployments of Blackwell and Grace Blackwell Compute	CI
06-09	Axe Compute Files $1 Billion Mixed Shelf	MT
05-27	Axe Compute Inc. Receives $43 Million Payment for Landmark Contract	CI
05-18	Axe Compute Inc., Q1 2026 Earnings Call, May 18, 2026
05-15	Axe Compute Inc. Reports Earnings Results for the First Quarter Ended March 31, 2026	CI
04-22	Top Midday Gainers	MT
04-22	Axe Compute Receives $260 Million Contract to Provide Nvidia B300 Chips; Shares Jump Pre-Bell	MT
04-22	Axe Compute Inc Secures $260 Million Three-Year Enterprise Contract for 2,304-GPU NVIDIA B300 Deployment	CI
04-20	Axe Compute Inc Announces Strategic Compute Reserve Dashboard Launch	CI

24-11-15	HC Wainwright Downgrades Predictive Oncology to Neutral From Buy	MT
21-06-30	PREDICTIVE ONCOLOGY : HC Wainwright Starts Predictive Oncology at Buy With $5 Price Target	MT

06-16	Axe Compute Secures $25.9 Million in Contracts for Long-Term Deployments of Blackwell and Grace Blackwell Compute	AQ
05-27	Axe Compute Receives $43M Payment for Landmark Contract	AQ
05-15	Axe Compute Inc. Reports First Quarter 2026 Financial Results and Provides Business Update	AQ
05-11	Axe Compute to Host Q1 2026 Financial Results Conference Call	AQ
05-04	Axe Compute Inc. (NASDAQ: AGPU) CEO Chris Miglino to Appear on Schwab Network May 4 and Cheddar May 6	AQ

21-03-16	MÄRKTE USA/Wall Street mit Fed-Sitzung in Lauerstellung
21-03-16	New Fortress Energy : MÄRKTE USA/Wall Street mit Fed-Sitzung uneinheitlich
21-03-16	New Fortress Energy : MÄRKTE USA/S&P-500 mit Rekordhoch trotz enttäuschender US-Daten
21-03-16	New Fortress Energy : MÄRKTE USA/Wenig verändert - US-Daten liefern gemischtes Bild
21-03-16	New Fortress Energy : MARKT USA/Wenig verändert - US-Daten könnten Impulse liefern

Precision Therapeutics Inc Stock Nasdaq

Stocks

US74033P1003

Biotechnology & Medical Research

Valuation: Precision Therapeutics Inc

Latest news : Precision Therapeutics Inc

Last Transcript: Precision Therapeutics Inc

Analysts' recommendations: Precision Therapeutics Inc

Press Releases: Precision Therapeutics Inc

News in other languages: Precision Therapeutics Inc

Quotes and Performance

Managers and Directors: Precision Therapeutics Inc

Other Biotechnology & Medical Research

Financials

Company Profile

Manager	Title	Age	Since
Christopher Miglino CEO	Chief Executive Officer	57	2026-02-08
Jeremy Yaukey-Witter DFI	Director of Finance/CFO	-	2026-04-15
Kyle Okamoto PSD	President	-	2026-03-31

Director	Title	Age	Since
Daniel Handley BRD	Director/Board Member	66	2020-02-18
Charles L. Nuzum CHM	Chairman	78	2026-02-08
Gregory St. Clair BRD	Director/Board Member	60	2020-07-08

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
PRECISION THERAPEUTICS INC	-7.56%	-8.33%	-	-	73.66M
LONZA GROUP AG	+1.70%	+7.41%	+2.50%	+8.22%	49.92B
REVOLUTION MEDICINES, INC.	+0.92%	+3.93%	+399.71%	+605.33%	40.23B
IQVIA HOLDINGS INC.	+1.89%	+8.32%	+26.06%	-6.35%	34.55B
BEONE MEDICINES AG	+2.38%	+6.35%	+21.25%	+64.58%	33.09B
CELLTRION, INC.	+3.96%	+10.67%	+8.30%	+40.44%	27.51B
ASCENDIS PHARMA A/S	+2.51%	+5.27%	-	-	17.05B
MEDPACE HOLDINGS, INC.	+2.58%	+5.79%	+73.44%	+133.27%	15.92B
EUROFINS SCIENTIFIC SE	+0.32%	+0.58%	+14.00%	+19.59%	13.86B
IONIS PHARMACEUTICALS, INC.	+3.30%	+0.76%	+90.23%	+99.12%	13.52B
Average	+1.20%	+5.82%	+79.44%	+120.52%	27.3B
Weighted average by Cap.	+2.06%	+6.53%	+90.20%	+137.91%

	2024	2025
Net sales	1.62M 1.42M 1.3M 1.22M 2.31M 155M 2.34M 15.66M 6.09M 76M 6.1M 5.96M 262M	125K 110K 101K 93.82K 178K 11.93M 181K 1.21M 470K 5.86M 470K 460K 20.21M
Net income	-12.66M -11.07M -10.17M -9.48M -17.99M -1.21B -18.26M -122M -47.48M -593M -47.54M -46.52M -2.04B	-233M -204M -187M -175M -331M -22.19B -336M -2.25B -874M -10.91B -875M -856M -37.59B
Net Debt	1.4M 1.22M 1.12M 1.05M 1.98M 133M 2.01M 13.47M 5.24M 65.35M 5.24M 5.13M 225M	-9.12M -7.98M -7.33M -6.83M -12.96M -869M -13.16M -88.01M -34.21M -427M -34.25M -33.51M -1.47B